Filed under: Analyst upgrades and downgrades, Research in Motion (RIMM), Rite Aid Corp (RAD)

MOST NOTEWORTHY: IMS Health, Ford Horizon Rite Aid were today’s noteworthy upgrades:

  • IMS Health (NYSE: RX) was upgraded to Neutral from Underperform at Baird on valuation.
  • Keefe Bruyette upgraded First Horizon (NYSE: FHN) to Market Perform from Underperform on valuation.
  • UBS upgraded Rite Aid (NYSE: RAD) to Buy from Neutral based on valuation and potential West Coast divestiture.

OTHER UPGRADES:

  • Schering-Plough (NYSE: SGP) was upgraded to Overweight from Equal Weight at Lehman.
  • Research in Motion (NASDAQ: RIMM) was upgraded to Outperform from Peer Perform at Bearn Stearns.
  • Kenexa (NASDAQ: KNXA) was upgraded to Buy from Accumulate at ThinkEquity.

Permalink | Email this | Comments

You might also be interested in these

Leave a Reply

Close
E-mail It